Burkina Faso

  1. Drawing on four decades of advocacy experience, PATH aims to play a catalytic role in advancing the practice of advocacy in health through fostering knowledge sharing, connection and collaboration among health advocates and other stakeholders. This learning brief highlights key takeaways from a virtual conversation between civil society advocates and a policymaker from Kenya, Uganda, and Burkina Faso about experiences and lessons in engaging policymakers for agenda and priority setting around PHC systems and policy implementation at national and regional levels.
    Published: December 2022
    Resource Page
    Brief
  2. S'appuyant sur quatre décennies d'expérience en matière de plaidoyer, PATH entend jouer un rôle de catalyseur pour promouvoir la pratique du plaidoyer dans le domaine de la santé en favorisant les échanges de connaissances, la connexion et la collaboration entre les acteurs de plaidoyer pour la santé et les autres parties prenantes. Ce dossier d'apprentissage met en lumière les principaux enseignements d'une conversation virtuelle entre les acteurs de la société civile et un responsable politique du Kenya, de l'Ouganda et du Burkina Faso sur les expériences et les leçons tirées de l'engagement des responsables politiques dans la définition de l'agenda et des priorités concernant les systèmes de SSP (soins de santé primaire) et la mise en œuvre des politiques aux niveaux national et régional.
    Published: December 2022
    Resource Page
    Brief
  3. Shigella is the leading bacterial cause of childhood diarrhea, and infections can have long-term effects on growth and development. No licensed Shigella vaccines currently exist, but several promising candidates in development could become available in a few years. PATH conducted a series of studies to better understand the public health value of potential Shigella vaccines and help inform decisions by international agencies, funders, vaccine developers, and national policymakers. This included a multi-country feasibility and acceptability study with national stakeholders and healthcare providers in Burkina Faso, Ghana, Kenya, Nepal, and Vietnam to identify preferences and priorities for future Shigella vaccines. These briefs provide an overview of the results in each of the study countries.
    Published: November 2022
    Resource Page
    Part of a Series, Brief
  4. As countries digitalize their health systems, health practitioners and ministries of health are learning what makes the development and introduction of digital health tools and approaches successful. However global policies and digital health investments often do not reflect the priorities and lessons that have emerged from these countries’ experiences.To bridge this gap, the Data Use Acceleration and Learning (DUAL) initiative collected learnings from its five focal countries and packaged them into a model for digital transformation for data use that evolves the World Health Organization (WHO) and International Telecommunication Union (ITU) eHealth Strategy Building Blocks.The DUAL model identifies ten core elements of a comprehensive approach to transforming a country’s health data systems and digital tools to advance data use. Rather than presenting a linear, step-by-step guide for digital transformation, it provides the “ingredients” for success that depend on and enable one another toward catalytic change.The DUAL report allows countries to identify the most appropriate starting point based on the priorities and digital maturity of their health systems. Each element is framed as a standalone chapter with key enabling factors, based on the evidence of what worked and what didn’t in the five focal countries DUAL studied. Specific actions are recommended for each enabling factor and country examples are used to illustrate the DUAL model at work.
    Published: October 2022
    Resource Page
    Report
  5. The New Nets Project was established with the goal of making the latest resistance breaking net technology more widely available to malaria programs throughout Africa. As well as managing the rapid deployment of new nets to partner countries and negotiating a volume guarantee to reduce prices, the New Nets Project partners oversee randomized control trials and pilots. The evidence gathered from these will be used to ascertain the impact and cost-effectiveness of the nets and support an appropriate policy recommendation from the World Health Organization. The New Nets Project is co-funded by Unitaid and The Global Fund, with complementary funding provided by the Bill & Melinda Gates Foundation and USAID. The project is led by IVCC. This slide deck shares interim findings across the epidemiology, entomology, human behavior, and durability monitoring components of the five observational studies led by PATH.
    Published: August 2022
    Resource Page
    Presentation
  6. The New Nets Project was established with the goal of making the latest resistance breaking net technology more widely available to malaria programs throughout Africa. As well as managing the rapid deployment of new nets to partner countries and negotiating a volume guarantee to reduce prices, the New Nets Project partners oversee randomized control trials and pilots. The evidence gathered from these will be used to ascertain the impact and cost-effectiveness of the nets and support an appropriate policy recommendation from the World Health Organization (WHO). The New Nets Project is co-funded by Unitaid and The Global Fund, with complementary funding provided by the Bill & Melinda Gates Foundation and USAID. The project is led by IVCC. This report shares interim findings from the five observational studies led by PATH.
    Published: July 2022
    Resource Page
    Report
  7. In many low- and middle-income countries, hundreds of thousands of people—including many newborns, children, and pregnant women—die needlessly each year from hypoxemia, or a low concentration of oxygen in the blood. Hypoxemia can be caused by a range of illnesses and complications, including pneumonia, neonatal infections, premature birth, obstetric emergencies, and respiratory infections like COVID-19.The COVID-19 pandemic has pointedly highlighted the lack of access to oxygen in lower-resource settings. The biggest barriers to oxygen therapy access include inadequate supply and human resource capacity, funding constraints, and the inability to deploy resources in countries rapidly in a way that ensures maximum impact while not overwhelming existing health care systems. The oxygen landscape is at a pivotal point where short-term pandemic-response efforts require continued support while transitioning to long-term, sustained strategies for ensuring access.This fact sheet offers an overview of the SOURCE project to support countries to equitably improve access to high-quality oxygen services at all levels of the health care system in order to reduce maternal, child, and overall mortality from hypoxemia-related causes. To do so, PATH will incorporate near-term pandemic-response work into a robust set of implementation, advocacy, and research activities that will ensure long-term access to medical oxygen and resilient systems for future pandemic-response efforts.
    Published: July 2022
    Resource Page
    Fact Sheet
  8. This report focuses on bed net indicators collected from annual cross-sectional surveys and anthropological activities. Within each evaluation, available indicators on bed net ownership, bed net characteristics, and bed net use are presented. Due to country-specific factors, the timing of data collection, management, and analysis varies. Data collection and analysis are ongoing, and definitive conclusions will not be drawn from these results at this time.The New Nets Project (NNP) was established with the goal of making the latest dual active ingredient (AI) insecticide-treated nets (ITNs) more widely available to malaria programs throughout sub-Saharan Africa. In addition to managing the rapid deployment of new nets to partner countries and negotiating a volume guarantee to reduce prices, NNP partners oversee randomized control trials and pilot studies evaluating their efficacy and effectiveness. The evidence gathered from these studies will be used to ascertain the impact and cost-effectiveness of dual AI nets and support an appropriate ITN policy recommendation from the World Health Organization. The NNP is co-funded by Unitaid and The Global Fund, with complementary funding provided by the Bill & Melinda Gates Foundation and US President’s Malaria Initiative. The project is led by IVCC.
    Published: May 2022
    Resource Page
    Report
  9. The goal of the antenatal care (ANC)-based malaria surveillance study is to assess the potential for pregnant women attending their first ANC visit to be used as an easy-to-access sentinel population at health facilities to monitor trends in prevalence of malaria infection and the coverage of malaria control interventions in study districts, correlated with similar metrics obtained during annual community-based cross-sectional surveys (CSS). The New Nets Project (NNP) is conducting annual cross-sectional surveys in three study districts each in Burkina Faso and western Mozambique and in four study local government areas in Nigeria, with the primary aim of evaluating the impact of next-generation dual active ingredient insecticide-treated nets (ITNs) compared to standard pyrethroid-only ITNs. Through funding from the Bill & Melinda Gates Foundation and The Global Fund, testing for malaria of all pregnant women at during their first ANC visit is being implemented at select health facilities in NNP study districts for two years (2020–2022).This descriptive report presents a summary of preliminary results generated from the first months of data collection in Burkina Faso, Mozambique, and Nigeria. It begins with an overview of the study sites and timeline, followed by a summary of the study population and data collection and analysis methods. The findings from each country are then presented, including prevalence and ITN and care-seeking indicators. Each country section closes with a discussion on the ANC-based surveillance results and how they seemingly compare to results from the annual household CSSs from the NNP.
    Published: May 2022
    Resource Page
    Report
  10. Mosquito nets treated with new ingredients show greater reductions in malaria than standard insecticide-treated nets.
    Published: December 2021
    Article